Angeles Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$834K Sell
2,304
-46
-2% -$15.7K 0.04% 179
2026
Q1
$827K Buy
2,350
+325
+16% +$116K 0.05% 165
2025
Q4
$663K Buy
2,025
+1,026
+103% +$325K 0.04% 173
2025
Q3
$282K Sell
999
-315
-24% -$91.4K 0.02% 267
2025
Q2
$367K Buy
1,314
+297
+29% +$84.1K 0.03% 224
2025
Q1
$317K Buy
1,017
+132
+15% +$39K 0.03% 197
2024
Q4
$231K Buy
885
+12
+1% +$3.56K 0.02% 262
2024
Q3
$281K Buy
873
+45
+5% +$14.7K 0.02% 214
2024
Q2
$259K Buy
828
+91
+12% +$26.7K 0.02% 199
2024
Q1
$210K Buy
+737
New +$216K 0.02% 206

Other funds holding AMGN

Angeles Wealth Management's AMGN Position: Q2 2026 in Review

Angeles Wealth Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $15.7K and leaving 2,304 shares worth $834K. The position accounts for 0.04% of the portfolio, ranked #179.

Angeles Wealth Management first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Angeles Wealth Management held 2,304 shares of Amgen worth $834K as of Q2 2026.
  • Angeles Wealth Management sold 46 Amgen shares in Q2 2026, an estimated $15.7K.
  • Amgen made up 0.04% of Angeles Wealth Management's portfolio in Q2 2026, its #179 holding.
  • Angeles Wealth Management first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.